<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>157(6)</volume><submitter>Offodile AC</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>In 2014, Maryland initiated the global budget revenue (GBR) model, placing caps on total hospital expenditures across all care sites. The GBR program aims to reduce unnecessary utilization while maintaining or improving care quality. To date, there has been limited examination of program effects on cancer care.&lt;h4>Objective&lt;/h4>To compare changes in spending, clinical outcomes, and acute care utilization through 4 years of the GBR program among Medicare beneficiaries who undergo cancer-directed surgery in Maryland vs matched control states.&lt;h4>Design, setting, and participants&lt;/h4>Drawing from a matched pool of hospitals in Maryland (n = 35) and 24 control states with a similar timing of Medicaid expansion (n = 101), we identified Medicare beneficiaries from Maryland and</pubmed_abstract><journal>JAMA surgery</journal><pagination>e220135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8988019</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Maryland Global Budget Revenue With Spending and Outcomes Related to Surgical Care for Medicare Beneficiaries With Cancer.</pubmed_title><pmcid>PMC8988019</pmcid><pubmed_authors>Melamed A</pubmed_authors><pubmed_authors>Lin YL</pubmed_authors><pubmed_authors>Kinzer D</pubmed_authors><pubmed_authors>Keating NL</pubmed_authors><pubmed_authors>Rauh-Hain JA</pubmed_authors><pubmed_authors>Offodile AC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Maryland Global Budget Revenue With Spending and Outcomes Related to Surgical Care for Medicare Beneficiaries With Cancer.</name><description>&lt;h4>Importance&lt;/h4>In 2014, Maryland initiated the global budget revenue (GBR) model, placing caps on total hospital expenditures across all care sites. The GBR program aims to reduce unnecessary utilization while maintaining or improving care quality. To date, there has been limited examination of program effects on cancer care.&lt;h4>Objective&lt;/h4>To compare changes in spending, clinical outcomes, and acute care utilization through 4 years of the GBR program among Medicare beneficiaries who undergo cancer-directed surgery in Maryland vs matched control states.&lt;h4>Design, setting, and participants&lt;/h4>Drawing from a matched pool of hospitals in Maryland (n = 35) and 24 control states with a similar timing of Medicaid expansion (n = 101), we identified Medicare beneficiaries from Maryland and</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2026-03-17T15:19:15.667Z</modification><creation>2025-04-05T11:56:28.694Z</creation></dates><accession>S-EPMC8988019</accession><cross_references><pubmed>35385085</pubmed><doi>10.1001/jamasurg.2022.0135</doi></cross_references></HashMap>